http://rdf.ncbi.nlm.nih.gov/pubchem/reference/14208551
Outgoing Links
Predicate | Object |
---|---|
contentType | Journal Article |
endingPage | 293 |
issn | 1948-5875 |
issueIdentifier | 4 |
pageRange | 292-293 |
publicationName | ACS Medicinal Chemistry Letters |
startingPage | 292 |
bibliographicCitation | Abdel-Magid AF. ATR Inhibitors as Potential Treatment for Cancers. ACS Med. Chem. Lett. 2018 Mar 15;9(4):292–3. doi: 10.1021/acsmedchemlett.8b00107. |
creator | http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_2536b061f4fa620b7f2922179c1028f6 |
date | 2018-03-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
identifier | https://pubmed.ncbi.nlm.nih.gov/29670686 https://doi.org/10.1021/acsmedchemlett.8b00107 https://pubmed.ncbi.nlm.nih.gov/PMC5900326 |
isPartOf | https://portal.issn.org/resource/ISSN/1948-5875 http://rdf.ncbi.nlm.nih.gov/pubchem/journal/37641 |
language | English |
source | https://pubmed.ncbi.nlm.nih.gov/ https://www.crossref.org/ |
title | ATR Inhibitors as Potential Treatment for Cancers |
Incoming Links
Total number of triples: 37.